GCVRX
Price
$24.23
Change
+$0.14 (+0.58%)
Updated
Jul 3 closing price
Net Assets
534.73M
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

GCVRX vs VIVAX

Header iconGCVRX vs VIVAX Comparison
Open Charts GCVRX vs VIVAXBanner chart's image
Goldman Sachs Large Cp Val Insghts R
Price$24.23
Change+$0.14 (+0.58%)
VolumeN/A
Net Assets534.73M
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
GCVRX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GCVRX vs. VIVAX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCVRX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. GCVRX (535M). VIVAX pays higher dividends than GCVRX: VIVAX (2.06) vs GCVRX (0.66). GCVRX was incepted earlier than VIVAX: GCVRX (18 years) vs VIVAX (33 years). GCVRX (1.27) is less costly to investors than VIVAX (0.17). GCVRX is a more actively managed with annual turnover of: 206.00 vs. VIVAX (9.00). GCVRX has a lower initial minimum investment than VIVAX: GCVRX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 11.40 vs. GCVRX (0.61). VIVAX return over 5 years is better than : 79.11 vs. GCVRX (34.75).
GCVRXVIVAXGCVRX / VIVAX
Total Expense Ratio1.170.17688%
Annual Report Gross Expense Ratio1.270.17747%
Fund Existence18 years33 years-
Gain YTD5.3565.60396%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets535M189B0%
Annual Yield % from dividends0.662.0632%
Returns for 1 year0.6111.405%
Returns for 3 years20.3334.3959%
Returns for 5 years34.7579.1144%
Returns for 10 years54.08114.5147%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLTX48.891.03
+2.15%
MoonLake Immunotherapeutics
EVER24.530.34
+1.41%
EverQuote
LPTH3.050.01
+0.33%
LightPath Technologies
STX149.44-2.50
-1.65%
Seagate Technology Holdings PLC
KAPA0.65-0.04
-6.33%
Kairos Pharma Ltd.